A new way to load therapeutic proteins into body-sized vesicles
Official title: Human-derived rheostat for therapeutic protein loading into extracellular vesicles
Funded at State University of Ny,binghamton · NIH-11355443 · Data updated 2026-11-12
A new method aims to pack specific therapeutic proteins into extracellular vesicles inside human cells, using a safe small molecule to trigger the process.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | State University of Ny,binghamton NIH-funded |
| Lab location | 1 site (Binghamton, United States) |
| Project start | July 1, 2026 |
| Project end | June 30, 2028 |
| Funding year | 2026 |
| Award (this year) | $455,610 |
| NIH project number | 1R21GM164987-01 |
| Project ID | NIH-11355443 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal participants would be adults affected by conditions related to diabetes or blood coagulation disorders where protein-based therapies could be relevant.
✕Less likely to help
People not involved in conditions that would benefit from targeted protein delivery may not experience direct advantages.
What this research studies
This project develops a technology to package chosen proteins into extracellular vesicles, potentially delivering therapeutic payloads in patients. It tests a bioorthogonal trigger that is non-toxic and works across different protein structures. The work combines protein chemistry, bioengineering, and chemistry to show the approach is feasible in human cells and scalable for future therapies.
Why it matters
Potential benefit: If successful, this approach could enable more precise and safer delivery of therapeutic proteins to patients.
How similar studies have gone: Early-stage work shows promise for vesicle-based delivery systems, but this exact technology is novel and foundational.
Where this research is happening
-
State University of Ny,binghamton
Binghamton, United States Active
Researchers
- Principal investigator: Callahan, Brian Patrick — State University of Ny,binghamton
- Study coordinator: Callahan, Brian Patrick
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.